Latest article
Novo Nordisk to launch GLP-1 injectible diabetes drug in pill type by February
Novo Nordisk, headquartered in Denmark and a leader in the diabetes market, plans to launch this oral GLP-1 drug in India by February 2022....
Pediatric diabetes is on the rise; mother and father urged to look out for...
Sign in to continuePrint subscribers? Sign up for full access!Please sign up for only 36 cents a day to continue viewing our website.Unlimited...
